Please note that it would be inaccurate to use the postings in this forum as a gauge of valve success or failure. The tissue valve people you will see still here are more likely to be those who have experienced an issue.
As far as the valves' histories, I am certain I published some dates long ago, but I just can't seem to coax them out with a search. However, here is what I could find today:
The Medtronic Mosaic porcine bioprosthesis was approved by the US FDA in 2000. It uses the same stent that was used by the Hancock valves that were already approved, but is otherwise largely dissimilar. The earliest reference I have yet found to pre-approval (clinical trial) implants was from February, 1994. Medtronic has been providing US-approved tissue valves for over 30 years, but not the Mosaic or a direct-line predecessor.
The first Edwards Perimount bovine valve was implanted in 1981, and the Perimount Magna was approved in 2004 (I don't have a date for the base Perimount approval). The Mitral version of the Magna was approved and released in 2008. An even newer version of the aortic Perimount Magna was approved in 2009 for easier implantation in minimally-invasive surgeries. According to their 20-year study: The data indicate that patients 60 years and older who receive a Carpentier-Edwards PERIMOUNT aortic valve will have a greater than 90% chance of not needing a new valve for 20 years. (250 patients)
St. Jude's Biocor was approved in the US in 2005. In its original form, it was first implanted in 1983. In Patients 65 and older, their 20year data study found that the Biocor valve's rate of freedom from reoperation for structural valve deterioration was 86.5 percent. (about 1,950 patients)
http://www.springerlink.com/content/n07164861h212l52/
Best wishes,
As far as the valves' histories, I am certain I published some dates long ago, but I just can't seem to coax them out with a search. However, here is what I could find today:
The Medtronic Mosaic porcine bioprosthesis was approved by the US FDA in 2000. It uses the same stent that was used by the Hancock valves that were already approved, but is otherwise largely dissimilar. The earliest reference I have yet found to pre-approval (clinical trial) implants was from February, 1994. Medtronic has been providing US-approved tissue valves for over 30 years, but not the Mosaic or a direct-line predecessor.
The first Edwards Perimount bovine valve was implanted in 1981, and the Perimount Magna was approved in 2004 (I don't have a date for the base Perimount approval). The Mitral version of the Magna was approved and released in 2008. An even newer version of the aortic Perimount Magna was approved in 2009 for easier implantation in minimally-invasive surgeries. According to their 20-year study: The data indicate that patients 60 years and older who receive a Carpentier-Edwards PERIMOUNT aortic valve will have a greater than 90% chance of not needing a new valve for 20 years. (250 patients)
St. Jude's Biocor was approved in the US in 2005. In its original form, it was first implanted in 1983. In Patients 65 and older, their 20year data study found that the Biocor valve's rate of freedom from reoperation for structural valve deterioration was 86.5 percent. (about 1,950 patients)
http://www.springerlink.com/content/n07164861h212l52/
Wouldn't you love to know what the other 1.1% got?Bioprostheses have become the predominant diseased aortic valve substitute for aortic valve replacement. The experience of the Society of Thoracic Surgeons was published in 2009 by Brown and colleagues [1] documenting that the use of bioprostheses increased from 42% in 1996 to 78.4% in 2006. The mechanical prostheses use declined to 20.5%. The use of bioprostheses for aortic valve replacement has increased in Western Europe but not to the same extent.
Best wishes,
Last edited: